ISC066-R03 3 ml ready-to-use (RTU)
ISC066-R07 7 ml ready-to-use (RTU)
ISC066-C02 0.2 ml concentrated
ISC066-C05 0.5 ml concentrated
Estrogen receptor(ER), belongs to a family of nuclear receptor proteins that contain a ligand-binding domain that maintains a non-activated conformation of the protein when it is not bound to a hormone. There are two main types of Estrogen receptors, ERα and ERβ, both have steroidal steroid ligand specificity, but the molecular mechanism of regulating ERβ transcription activity is different from that of ERα. The estrogen receptor (ER) is a regulator of mammary epithelial growth, proliferation, and differentiation whose complex cellular interactions are mediated by a multitude of ligands, cofactors, and other stimuli. ER is expressed in the prostate, ovary and other reproductive organs. ER is important for normal breast development and function, but also plays a role in the development and progression of breast cancer.
The stated primary antibody is suitable for immunohistochemical staining of FFPE tissue sections based on specific antigen-antibody reaction. Using a detection system linked to HRP or alkaline phosphatase the antigen visualization is performed via specific binding of the primary antibody. Secondary antibody is binding to the primary antibody, and the enzyme complex labels this complex. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. Each step is incubated for a precise time and temperature and requires interposed washing steps. The specimen may then be counterstained. Results are interpreted using a light microscope.
The immunostaining procedure causes a colored reaction product to precipitate at the antigen sites localized by the primary antibody.
Cellular localization: Nuclear.
A qualified pathologist experienced in immunohistochemistry procedures must evaluate positive and negative tissue controls before interpreting patient specimens.
Positive staining intensity should be assessed within the context of any background staining of the negative reagent control.
Note: A negative result means that the antigen in question was not detected, but not that the antigen is not present in the cells/tissues tested. An antibody panel may be used to support the results in some circumstances. Additionally, the morphology of each tissue sample should be examined utilizing a hematoxylin and eosin stained section. A qualified pathologist must interpret the patient’s morphologic findings and pertinent clinical data.
See MSDS.
| Primary antibody | Anti-Estrogen Receptor |
| Host | Rabbit |
| Subclass | IgG |
| Clone | ISR030 |
| Species Cross-reactivity | Human. Others-not known |
| Applications | Immunohistochemistry |
| Epitope Retrieval | Heat-induced epitope retrieval |
| Ready-to-use antibody | Prediluted antibody in antibody diluent buffer |
Product label shows the specific lot number.
Prediluted antibody is ready-to-use and optimized for staining. No further dilution, reconstitution, mixing, or titration is needed.
The following materials may be required for staining but are not provided with the primary antibody.
– Positive and negative controls
– Microscope slides (positively charged) and cover slips
– Water bath
– Humidified chamber
– Staining jars
– Stopwatch
– Xylene or xylene substitute
– Ethanol
– Deionized or distilled water
– Antigen retrieval reagent, e.g. Antigen Enhancer (HIER buffer), Cat. No. BUAN01-500
– Detection system, e.g. IHC Complete Detection system (Goat anti mouse/rabbit HRP, DAB staining), Cat. No. D001-15
– Wash buffer: e.g. IHC Wash Buffer, Cat. No. BUWA01-1000
– Tap water/bluing reagent (e.g. ammonia water)
– Light microscope
Store at 2 – 8 °C.
When stored correctly antibody is stable to the expiration date indicated on the vial. Do not use after expiration date.
To ensure proper reagent delivery and stability of the antibody, replace the dispenser cap after every use and immediately place the bottle cool in an upright position.
[1] Diaz L K, Sneige N. Estrogen receptor analysis for breast cancer: current issues and keys to increasing testing accuracy[J]. Advances in anatomic pathology, 2005, 12(1): 10-19.
[2] Gomez-Fernandez C, Mejias A, Walker G, et al. Immunohistochemical expression of estrogen receptor in adenocarcinomas of the lung: the antibody factor[J]. Applied immunohistochemistry & molecular morphology, 2010, 18(2): 137-141.
[3] Ilić I R, Stojanović N M, Radulović N S, et al. The quantitative ER immunohistochemical analysis in breast cancer: Detecting the 3+ 0, 4+ 0, and 5+ 0 allred score cases[J]. Medicina, 2019, 55(8): 461.
2024-06-10
Change(s) made: